Antibody‐drug conjugate MORAb‐202 exhibits long‐lasting antitumor efficacy in TNBC PDx models

por Furuuchi, Keiji, Rybinski, Katherine, Fulmer, James, Moriyama, Tomoyuki, Drozdowski, Brian, Soto, Allis, Fernando, Shawn, Wilson, Kerrianne, Milinichik, Andrew, Dula, Mary Lou, Tanaka, Keigo, Cheng, Xin, Albone, Earl, Uenaka, Toshimitsu
Publicado 2021